1.
Sen S. Canagliflozin (Invokana®): a First-in-Class Anti-diabetic Drug. J. Drug Delivery Ther. [Internet]. 2013 May 13 [cited 2026 Jan. 22];3(3):145-6. Available from: https://jddtonline.info/index.php/jddt/article/view/490